vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and SolarMax Technology, Inc. (SMXT). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $46.6M, roughly 1.0× SolarMax Technology, Inc.). SolarMax Technology, Inc. runs the higher net margin — -1.9% vs -4.8%, a 2.9% gap on every dollar of revenue. On growth, SolarMax Technology, Inc. posted the faster year-over-year revenue change (623.5% vs -47.3%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
SolarMax Technology, Inc. develops, manufactures and sells high-efficiency solar PV modules and clean energy systems. It serves residential, commercial and industrial clients in North America and key Asia-Pacific markets, offering installation and after-sales support to boost low-carbon energy use.
IRWD vs SMXT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $46.6M |
| Net Profit | $-2.3M | $-872.2K |
| Gross Margin | — | 2.7% |
| Operating Margin | 14.3% | -2.7% |
| Net Margin | -4.8% | -1.9% |
| Revenue YoY | -47.3% | 623.5% |
| Net Profit YoY | -200.9% | 77.7% |
| EPS (diluted) | $0.01 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $46.6M | ||
| Q3 25 | $122.1M | $30.6M | ||
| Q2 25 | $85.2M | $6.9M | ||
| Q1 25 | $41.1M | $6.9M | ||
| Q4 24 | $90.5M | $6.4M | ||
| Q3 24 | $91.6M | $6.3M | ||
| Q2 24 | $94.4M | — | ||
| Q1 24 | $74.9M | — |
| Q4 25 | $-2.3M | $-872.2K | ||
| Q3 25 | $40.1M | $-2.3M | ||
| Q2 25 | $23.6M | $-1.9M | ||
| Q1 25 | $-37.4M | $-1.3M | ||
| Q4 24 | $2.3M | $-3.9M | ||
| Q3 24 | $3.6M | $-9.6M | ||
| Q2 24 | $-860.0K | — | ||
| Q1 24 | $-4.2M | — |
| Q4 25 | — | 2.7% | ||
| Q3 25 | — | 3.1% | ||
| Q2 25 | — | 8.8% | ||
| Q1 25 | — | 20.5% | ||
| Q4 24 | — | 14.5% | ||
| Q3 24 | — | 19.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 14.3% | -2.7% | ||
| Q3 25 | 61.8% | -6.9% | ||
| Q2 25 | 53.2% | -25.7% | ||
| Q1 25 | -70.7% | -16.7% | ||
| Q4 24 | 34.8% | -27.9% | ||
| Q3 24 | 28.0% | -158.4% | ||
| Q2 24 | 26.5% | — | ||
| Q1 24 | 14.7% | — |
| Q4 25 | -4.8% | -1.9% | ||
| Q3 25 | 32.8% | -7.4% | ||
| Q2 25 | 27.7% | -27.6% | ||
| Q1 25 | -90.9% | -18.7% | ||
| Q4 24 | 2.5% | -60.6% | ||
| Q3 24 | 4.0% | -152.0% | ||
| Q2 24 | -0.9% | — | ||
| Q1 24 | -5.6% | — |
| Q4 25 | $0.01 | $-0.02 | ||
| Q3 25 | $0.23 | $-0.04 | ||
| Q2 25 | $0.14 | $-0.04 | ||
| Q1 25 | $-0.23 | $-0.03 | ||
| Q4 24 | $0.03 | $-0.07 | ||
| Q3 24 | $0.02 | $-0.21 | ||
| Q2 24 | $-0.01 | — | ||
| Q1 24 | $-0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $8.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $-12.2M |
| Total Assets | $396.9M | $91.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $8.0M | ||
| Q3 25 | $140.4M | $5.7M | ||
| Q2 25 | $92.9M | $1.9M | ||
| Q1 25 | $108.5M | $6.8M | ||
| Q4 24 | $88.6M | $7.1M | ||
| Q3 24 | $88.2M | $8.6M | ||
| Q2 24 | $105.5M | — | ||
| Q1 24 | $121.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $-12.2M | ||
| Q3 25 | $-264.2M | $-11.8M | ||
| Q2 25 | $-308.2M | $-15.1M | ||
| Q1 25 | $-334.1M | $-15.9M | ||
| Q4 24 | $-301.3M | $-15.1M | ||
| Q3 24 | $-311.3M | $-10.9M | ||
| Q2 24 | $-321.7M | — | ||
| Q1 24 | $-330.5M | — |
| Q4 25 | $396.9M | $91.3M | ||
| Q3 25 | $396.1M | $58.7M | ||
| Q2 25 | $342.9M | $38.2M | ||
| Q1 25 | $327.2M | $38.6M | ||
| Q4 24 | $350.9M | $38.6M | ||
| Q3 24 | $389.5M | $43.0M | ||
| Q2 24 | $395.6M | — | ||
| Q1 24 | $438.8M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $-2.5M |
| Free Cash FlowOCF − Capex | $74.6M | — |
| FCF MarginFCF / Revenue | 156.3% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $-2.5M | ||
| Q3 25 | $47.6M | $3.4M | ||
| Q2 25 | $-15.1M | $220.7K | ||
| Q1 25 | $20.0M | $-601.1K | ||
| Q4 24 | $15.2M | $-1.3M | ||
| Q3 24 | $9.9M | $203.6K | ||
| Q2 24 | $33.5M | — | ||
| Q1 24 | $45.0M | — |
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $-15.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.4M | — | ||
| Q1 24 | $44.9M | — |
| Q4 25 | 156.3% | — | ||
| Q3 25 | 39.0% | — | ||
| Q2 25 | -17.7% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 35.4% | — | ||
| Q1 24 | 60.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
SMXT
| Yabucoa | $35.9M | 77% |
| Other | $10.7M | 23% |
